Chemotherapy in India typically costs between ₹20,000 and ₹1,00,000 per cycle, with total treatment costs ranging from a few lakhs to well over ₹20 lakhs depending on the cancer type, drug protocol, and hospital. That’s a wide range because “chemotherapy” isn’t one treatment. It’s dozens of different drug combinations, each priced differently, administered over varying numbers of cycles, in hospitals that charge vastly different rates.
Cost Per Cycle by Cancer Type
The per-cycle price depends heavily on which cancer you’re treating and whether you use Indian generics or branded drugs. For breast cancer, standard chemotherapy using generic drugs runs about ₹8,000 to ₹15,000 per cycle across 4 to 12 cycles. If the cancer is HER2-positive and requires targeted therapy like trastuzumab, the cost jumps to ₹20,000 to ₹35,000 per cycle for biosimilars, or ₹60,000 to ₹1.1 lakh per cycle for the original branded version, and treatment continues for a full year (12 to 18 cycles). Six rounds of tailored breast cancer chemotherapy can exceed ₹20 lakhs.
Lung cancer treatment varies even more dramatically. First-line chemotherapy with generics costs ₹12,000 to ₹20,000 per cycle for 4 to 6 cycles. But if you need oral targeted therapy (a daily pill taken indefinitely), the monthly cost ranges from ₹3,000 to ₹6,000 for older generics, while newer targeted drugs can run ₹1.5 to ₹2 lakh per month in generic form and over ₹4 lakh per month for branded versions.
For brain, thoracic, abdominal, and kidney cancers, total treatment costs including radiation, surgery, and diagnostics generally fall between ₹7 and ₹10 lakhs. Brain and breast tumour treatment can climb as high as ₹16 lakhs.
Generic vs. Branded Drugs
India’s generic pharmaceutical industry is one of the biggest factors keeping chemotherapy costs lower here than almost anywhere else in the world. The price difference between a government-subsidized generic and the costliest branded version of the same drug can be staggering. For doxorubicin, a widely used chemotherapy drug, the branded version costs over 33 times more than the generic available through the government’s Jan Aushadhi scheme. Across the board, switching to generics can save roughly 15% on total medication costs, and for certain drugs the savings are far greater.
This is a conversation worth having with your oncologist. Indian generics undergo regulatory approval and are widely used in both government and private hospitals. For many standard chemotherapy protocols, they are the default choice.
Government Hospitals vs. Private Hospitals
The gap between government-aided institutions and private corporate hospitals is enormous. At Tata Memorial Hospital in Mumbai, India’s premier cancer centre, the poorest patients pay nothing for chemotherapy planning, daycare charges, and indoor admission. Even in its higher-paying categories, daycare charges run ₹660 to ₹1,295 per day, and intravenous chemotherapy administration costs ₹240 to ₹2,340 per cycle. These figures cover only the hospital’s service charges (drugs are separate), but they’re a fraction of what private hospitals bill.
Private hospitals in metro cities charge ₹15,000 to ₹5,00,000 per cycle depending on the protocol. The wide range reflects both the drug choice and the hospital’s own pricing. A cycle of standard chemotherapy at a private hospital in Delhi or Mumbai will cost significantly more than the same protocol at a government or trust hospital, even when the drugs are identical.
Costs Beyond the Drugs
The chemotherapy drug itself is only part of the bill. Before treatment begins, you’ll need diagnostic tests. A whole-body PET-CT scan costs ₹10,000 to ₹40,000. Biopsies range from ₹2,000 to ₹12,000 per site (excluding the pathology analysis). Tumour marker panels run ₹1,000 to ₹8,000 per series. These tests are essential for staging the cancer and choosing the right treatment plan, and some need to be repeated during treatment to track progress.
During chemotherapy, supportive medications add up quickly. Anti-nausea drugs, growth factor injections to boost white blood cell counts, blood transfusions, and infection management are common additions. Daycare or admission charges apply each time you receive a cycle. If you’re traveling to a different city for treatment, factor in accommodation, travel, and the income lost during months of therapy. For many Indian families, these indirect costs rival the medical bills themselves.
Immunotherapy and Advanced Treatments
If your oncologist recommends immunotherapy or other advanced options, the costs escalate significantly. Checkpoint inhibitors, used for cancers like melanoma and lung cancer, range from ₹2,500 to ₹1,50,000 per cycle. Monoclonal antibodies cost ₹1,50,000 to ₹4,00,000 per cycle. CAR T-cell therapy, a personalized treatment primarily for blood cancers, costs ₹30 to ₹60 lakhs for the full treatment.
These therapies are not always necessary. Standard chemotherapy remains the first-line treatment for most cancers. But when advanced options are recommended, they can push total treatment costs well beyond what families anticipate.
Financial Support Options
The Ayushman Bharat scheme (PM-JAY) covers cancer treatment for eligible families, though the package rates are fixed and may not cover the full cost at private hospitals. For example, the scheme’s rate for breast cancer chemotherapy using a standard protocol is ₹19,800. For acute myeloid leukemia induction chemotherapy, the package rate is ₹96,000. These packages cover the treatment episode, not the full course, so multiple claims may be needed across cycles.
Beyond government insurance, most state governments run cancer-specific welfare funds. Trust hospitals like Tata Memorial and regional cancer centres offer subsidized or free treatment based on income. Many pharmaceutical companies also run patient assistance programs that provide expensive targeted therapy drugs at reduced cost or free of charge to patients who qualify. Asking the hospital’s medical social worker about all available schemes before starting treatment is one of the most practical steps you can take to reduce your out-of-pocket burden.
Why India Is a Medical Tourism Destination for Cancer Care
Cancer drug prices are highest in the United States, and India’s generic drug ecosystem makes the same treatments available at a fraction of the cost. A course of chemotherapy that might cost $10,000 to $100,000+ in the US can often be completed for ₹2 to ₹15 lakhs in India, depending on the protocol. This price gap has made India a major destination for international patients seeking affordable oncology care.
That said, an important nuance often gets lost: while absolute drug prices in India are among the lowest in the world, cancer drugs are actually the least affordable in India relative to income. A study comparing global cancer drug costs found that Indian patients face the worst affordability gap of any country studied. The cost of targeted therapy for HER2-positive breast cancer, for instance, is roughly equivalent to ten years of average annual income in India. So while the sticker price is low by international standards, the financial burden on Indian families is disproportionately high.